polyisobutylene
Small moleculeexperimental
Polyisobutene (polyisobutylene) is a class of organic polymers prepared by polymerization of isobutene. The polymers often have the formula Me3C[CH2CMe2]nH (Me = CH3). They are typically colorless gummy solids. — Wikipedia
Clinical trial activity
1 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Jul 10, 2019 (NCT04017195)
Timeline
2010s
- Jan 1, 2019
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Unspecified targetUnclear
unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Sources
- WikipediaPolyisobutene ↗
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT04017195 | Phase 1 | Jul 10, 2019 | Janssen Pharmaceutica NV |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Janssen Pharmaceutica NV | For profit | 1 | 1 | 1 | 2019 |
1 organizations
Page 1 / 1